ACURE PHARMA AB has a total of 26 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are REVOTAR BIOPHARMACEUTICALS AG, GR NENTHAL GMBH and CEREBRUS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 3 | |
#4 | United States | 3 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Mexico | 2 | |
#8 | Australia | 1 | |
#9 | Hong Kong | 1 | |
#10 | New Zealand | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Boman Arne | 17 |
#2 | Lek Per | 16 |
#3 | Seifert Elisabeth | 15 |
#4 | Lundstedt Torbjoern | 11 |
#5 | Skottner Anna | 9 |
#6 | Lundstedt Torbjorn | 8 |
#7 | Kalvins Ivars | 3 |
#8 | Andrianov Victor | 3 |
#9 | Ekstroem Gunilla | 1 |
#10 | Arne Boman | 1 |
Publication | Filing date | Title |
---|---|---|
GB0901071D0 | Anti-inflammatory compounds | |
GB0808827D0 | Novel pharmaceutically active compounds | |
GB0801284D0 | Novel tertiary amides and amines | |
NZ576781A | Novel amides acting on the adenosine receptors | |
GB0624987D0 | Novel aminoguanidines as melanocortin receptor ligands | |
GB0623381D0 | Use of a compound as VEGF inhibitor | |
GB0617280D0 | Compositions and methods for the treatment of neurological damage | |
ZA200707955B | Methods and pharmaceutical compositions for the treatment of neurological damage |